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Mechanistic insights into the inhibition of Sec61-dependent
co- and post-translational translocation by mycolactone
Michael McKenna1, Rachel E. Simmonds2 and Stephen High1,*
ABSTRACT
The virulence factor mycolactone is responsible for the
immunosuppression and tissue necrosis that characterise Buruli
ulcer, a disease caused by infection with Mycobacterium ulcerans.
In this study, we confirm that Sec61, the protein-conducting channel
that coordinates entry of secretory proteins into the endoplasmic
reticulum, is a primary target of mycolactone, and characterise the
nature of its inhibitory effect. We conclude that mycolactone
constrains the ribosome–nascent-chain–Sec61 complex, consistent
with its broad-ranging perturbation of the co-translational
translocation of classical secretory proteins. In contrast, the effect
of mycolactone on the post-translational ribosome-independent
translocation of short secretory proteins through the Sec61 complex
is dependent on both signal sequence hydrophobicity and the
translocation competence of the mature domain. Changes to
protease sensitivity strongly suggest that mycolactone acts by
inducing a conformational change in the pore-forming Sec61α
subunit. These findings establish that mycolactone inhibits Sec61-
mediated protein translocation and highlight differences between the
co- and post-translational routes that the Sec61 complex mediates.
We propose that mycolactone also provides a useful tool for further
delineating the molecular mechanisms of Sec61-dependent protein
translocation.
KEY WORDS: Buruli ulcer, Endoplasmic reticulum, Mycobacterium
ulcerans, Mycolactone, Sec61, Short secretory protein
INTRODUCTION
Mycolactone is a polyketide-derived virulence factor produced by
Mycobacterium ulcerans, the pathogen responsible for the tropical
disease Buruli ulcer (George et al., 1999). Buruli ulcer is
characterised by chronic and extensive progressively necrotising
skin ulcers (Walsh et al., 2011), and histopathology reveals atypical
clusters of extracellular bacilli, as well as an absence of infiltrating
immune cells (Silva et al., 2009). Mycolactone is responsible for
these symptoms, and strains that lack its polyketide-synthase-
encoding plasmid produce only short-lived granulomatous
infections (Stinear et al., 2004). Mycolactone has been implicated
in the under-production of several proteins that are involved in the
inflammatory response (Hall et al., 2014; Pahlevan et al., 1999;
Simmonds et al., 2009; Torrado et al., 2007), and it is responsible
for impaired cell adhesion (Guenin-Macé et al., 2013) as well as a
lack of pain reception in patients (Marion et al., 2014). Despite the
broad inhibition of protein production observed in Buruli ulcer,
mycolactone has no direct negative effect on either transcription or
translation of the affected proteins (Boulkroun et al., 2010; Hall
et al., 2014; Simmonds et al., 2009). Instead, mycolactone blocks
the Sec61-dependent translocation of proteins into the endoplasmic
reticulum (ER) leading to their rapid degradation (Hall et al., 2014;
Ogbechi et al., 2015), though the precise mechanism by which this
occurs is unclear.
Proteins that are synthesised in the cytosol and targeted to the ER
include secretory and membrane-embedded proteins, and are often
characterised by a hydrophobic stretch of amino acids at or near
their N-terminus termed the ‘signal sequence’ (Blobel and
Dobberstein, 1975). The majority of these proteins are delivered
co-translationally to the ER of mammalian cells (Nyathi et al.,
2013). In this pathway, the signal sequence is recognised by the
signal recognition particle (SRP) upon emerging from the ribosomal
exit tunnel, and the rate of translation is slowed, allowing the
substrate to be targeted to the ER as part of a ribosome–nascent-
chain complex (RNC) (Mary et al., 2010;Walter andBlobel, 1981a,b;
Walter et al., 1981). At the ER, the RNC interacts first with the SRP
receptor (Gilmore et al., 1982a,b), and subsequently with the Sec61
translocon (Song et al., 2000), at which point translation continues
and protein translocation into the ER lumen occurs.
Some proteins are unable to use the co-translational pathway for
entry into the ER and must be delivered post-translationally.
These include tail-anchored proteins, which possess a hydrophobic
C-terminal targeting sequence that only emerges from the ribosomal
exit tunnel after translation has been terminated. Tail-anchored
proteins utilise a post-translational pathway that is dependent on
TRC40 (also known as ASNA1) to reach the ER, and upon delivery
are integrated into the ER membrane in a Sec61-independent
manner (Hegde and Keenan, 2011). Another group of proteins
capable of using a post-translational route to the ER are the short
secretory proteins (SSPs), whose short mature domain means that
translation is often terminated before their N-terminal signal
sequence has the opportunity to interact co-translationally with
SRP (Johnson et al., 2013b). Cytosolic factors, including
calmodulin (Shao and Hegde, 2011) and TRC40 (Johnson et al.,
2012), have been implicated in promoting SSP delivery to the ER
but, in contrast to the integration of tail-anchored proteins, the
translocation of SSPs across the ER membrane is dependent on
Sec61. Hence, both the small-molecule inhibitor eeyarestatin (Cross
et al., 2009; Johnson et al., 2012), and the siRNA-mediated
depletion of Sec61α (Lang et al., 2012) perturb the translocation of
model SSPs into the ER lumen.
The Sec61 translocon is a heterotrimeric membrane protein
complex [comprising Sec61α1 (isoform 1), Sec61β and Sec61γ]
that is an essential component for protein translocation into the ER
(Görlich and Rapoport, 1993). Based on structural studies of theReceived 28 October 2015; Accepted 3 February 2016
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equivalent archaeal complex (Van den Berg et al., 2004), the
Sec61α subunit is proposed to have ten transmembrane domains
that form a gated protein-conducting channel across the ER
membrane, as well as a ‘lateral gate’ that allows partitioning of
hydrophobic domains into the lipid phase of the ER membrane
(Martoglio et al., 1995). Recent high-resolution structural studies of
the eukaryotic translocon have vastly improved our understanding
of Sec61-dependent translocation (Becker et al., 2009; Gogala et al.,
2014; Pfeffer et al., 2015; Voorhees et al., 2014; Voorhees and
Hegde, 2016), and it is clear that this process is concomitant with
conformational changes of the Sec61 complex that constitute
channel gating.
The co-translational pathway is highly efficient, with GTP-
dependent protein synthesis providing the force necessary for
unidirectional translocation through the Sec61 translocon. Although
in some instances this process requires the ribosome, Sec61 and
SRP receptor only (Görlich and Rapoport, 1993), auxiliary factors,
such as the TRAM protein and the TRAP complex, can often
enhance translocation in a signal sequence-specific manner (Fons
et al., 2003; Lang et al., 2012; Voigt et al., 1996). In contrast, the
Sec61-mediated, post-translational translocation of many SSPs,
typically less than 120 residues long, is dependent upon Sec62, but
shows no requirement for SRP receptor (Lakkaraju et al., 2012).
Indeed, a recent study suggests that the Sec61 translocon exists in
two mutually exclusive states – a co-translational (SRP-receptor-
bound) state and a post-translational (Sec62-bound) state (Jadhav
et al., 2015). Likewise, in the absence of ongoing protein synthesis,
the directionality of post-translational translocation is provided by
ER luminal components, most notably BiP (also known as HSPA5)
(Matlack et al., 1999; Schäuble et al., 2012; Tyedmers et al., 2003).
In short, although the Sec61 complex can mediate both co- and post-
translational translocation into the ER, there is evidence that these
two pathways are mechanistically distinct.
In this study, we establish that mycolactone induces a
conformational change in Sec61α, the central component of the
ER translocon. This change correlates with distinct perturbations
of both co- and post-translational translocation pathways into the
ER. For example, although we observe efficient and indiscriminate
inhibition of co-translational ER translocation, short and
unstructured precursors that employ a post-translational route are
less prone to mycolactone-mediated inhibition of the Sec61
complex. We conclude that mycolactone induces a wide-ranging,
but by no means global, block on ER translocation. Taken together,
our findings highlight the complexity of ER translocation and
establish mycolactone as an important tool for understanding
different modes of Sec61-mediated translocation.
RESULTS
Mycolactone efficiently inhibits co-translational
translocation of secretory proteins
To assess the ability of mycolactone to inhibit protein translocation
into and across the endoplasmic reticulum (ER) membrane, mRNA
coding for potential substrates was translated in vitro using rabbit
reticulocyte lysate (RRL) in the presence of ER-derived canine
pancreatic rough microsomes (Hall et al., 2014). Efficient
translocation across or insertion into the rough microsomes can
be detected by signal sequence cleavage (‘c’ versus ‘nc’) and/or
N-glycosylation (‘+1g’ and/or ‘+2g’), depending on the substrate
being studied (Fig. S1A). Substrates lacking endogenous
glycosylation sites include an additional C-terminal opsin tag
termed ‘OPG’ or ‘OPG2’ (one or two consensus N-glycosylation
sites, respectively) where indicated. Given that mycolactone does
not directly affect translation (Hall et al., 2014), a reduction in the
amount of membrane-associated processed substrate provides a
reliable readout for an inhibition of ER translocation.
As previously described (Hall et al., 2014), the co-translational
translocation of yeast prepro-α-factor (PPαF) was effectively
blocked by mycolactone (Fig. 1A). Likewise, efficient processing,
and hence ER translocation, of the classic secretory protein
precursors preprolactin (PPL, also known as PRL) and
preprosaposin (PSAP) was seen in the absence but not in the
presence of mycolactone (Fig. 1A). In contrast, the membrane
integration of four different tail-anchored proteins was unaffected
by mycolactone (Fig. 1B). These findings support our proposal that
mycolactone targets a key component of the co-translational
translocation pathway that is not involved in tail-anchored protein
biogenesis (Fig. S1B). Our data also clearly show that mycolactone
does not interfere with N-glycosylation within the ER lumen per se,
and hence this modification provides a faithful readout for
mycolactone-induced inhibition of ER translocation.
Mycolactone alters the interaction between the RNC
complex and the Sec61 translocon
Previous studies have identified several different stages of the co-
translational translocation pathway at which inhibitors can act,
including SRP binding, RNC transfer to the ER, and polypeptide
translocation through the Sec61 complex (Kalies and Römisch,
2015). We therefore set out to define the point at which mycolactone
perturbs co-translational translocation (Fig. 2A). To this end, mRNA
coding for a truncated version of PPL that lacks a stop codon (PPL86,
Fig. 2B) was translated in vitro to generate a stable RNC complex that
results in a trapped translocation intermediate (Gilmore et al., 1991).
The nearest neighbours of these artificial translocation intermediates
Fig. 1. Mycolactone blocks co-translational translocation
into the ER but does not affect tail-anchored protein
integration. Phosphorimage of the indicated in vitro synthesised
co-translational substrates (A) or tail-anchored proteins (B) in the
presence or absence of mycolactone (Myco). Samples were
treated with endoglycosidase H (EndoH) where indicated to
distinguish glycosylated (+g) from non-glycosylated (0g) bands.
nc, signal sequence not cleaved; c, signal sequence cleaved.
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can then be investigated by employing protein crosslinking
techniques (Cross et al., 2009; MacKinnon et al., 2014).
To address the possibility that mycolactone affects the ability of
nascent PPL86 chains to interact with SRP (Fig. 2A, scenario i),
RNCs were generated in the absence of rough microsomes to enable
SRP binding, and the samples were treated with the bifunctional
amine-reactive crosslinking reagent disuccinimidyl suberate (DSS).
Immunoprecipitation using antisera raised against the 54-kDa
subunit of SRP (SRP54) confirmed the identity of discreet
crosslinking between it and nascent PPL86, which persisted when
Fig. 2. Mycolactone alters the interaction between RNCs and the Sec61 complex. (A) Diagram of the co-translational pathway with potential sites of
mycolactone inhibition indicated. Scenario (i) – mycolactone might interfere with the ability of the signal sequence to engage SRP. Scenario (ii) – mycolactone
might prevent the transfer of RNCs from the SRP receptor to the Sec61 complex, perhaps by preventing a productive interaction between these two components.
Scenario (iii) – mycolactone might alter the interaction of RNCs with the Sec61 complex. (B) Schematic of PPL truncations used for crosslinking analysis in this
study, with cysteine residues highlighted. (C) Phosphorimage of DSS-crosslinked (crosslinking indicated by ‘x’) PPL86 that had been in vitro translated with or
without mycolactone (Myco) and in the absence of rough microsomes. Samples were immunoprecipitated (IP) using antisera raised against either PPL (P) or
SRP54 (S). Control samples were mock immunoprecipitated with pre-immune rabbit serum (PI). In addition to an adduct with SRP54 (PPL86×SRP54), a higher
molecular mass species is also observed (*). We speculate that this most likely represents an adduct that contains an additional component such as SRP19.
Phosphorimages of BMH-crosslinked crosslinked PPL86 (D) and PPL75 (E) that had been in vitro translated with or without mycolactone and in the presence of
rough microsomes. Samples were immunoprecipitated after carbonate extraction using antisera raised against either PPL (P), Sec61α (‘α’) or Sec61β (‘β’).
(F) Phosphorimage of BMH-crosslinked PPL75 and PPL75 C25A that had been in vitro translated with or without mycolactone.
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the PPL86-RNCs were generated in the presence of mycolactone
(Fig. 2C, lane 3 versus lane 6). The persistence of the
PPL86×SRP54 adduct in the presence of mycolactone was also
confirmed using the alternative crosslinking reagent SMCC
(Fig. S2A). We therefore conclude that mycolactone does not
perturb the binding of SRP to nascent PPL86 chains.
When PPL86-RNCs were generated in the presence of rough
microsomes, the nascent chain formed a strong crosslink with
Sec61α when treated with the thiol-selective crosslinking reagent
bismaleimidohexane (BMH) (Fig. 2D, lane 6). Strikingly, this
adduct almost completely disappeared in the presence of
mycolactone (Fig. 2D, lane 8). To establish whether this loss of
crosslinking to Sec61α represents a failure of the RNC to reach the
Sec61 complex (Fig. 2A, scenario ii), a shorter nascent PPL chain
(PPL75, Fig. 2B) that potentially reflects an earlier stage of the ER
translocation process (Laird and High, 1997) was analysed. PPL75
generates adducts to both Sec61α and Sec61β (Fig. 2E), and
whereas the adduct with Sec61α was clearly diminished in the
presence of mycolactone (Fig. 2E, lane 3 versus lane 7),
crosslinking to Sec61β was noticeably enhanced (Fig. 2E, lane 4
versus lane 8). The amino acid residue primarily responsible for
these adducts was identified as Cys25 within the PPL signal
sequence (Fig. 2B,F; Fig. S2B). Furthermore, mycolactone showed
no ability to prevent the re-binding of ribosomes to ER-derived
microsomes that had been first stripped of ribosomes by EDTA
treatment and high-salt washing (Fig. S2D). Given that ribosome
binding at ER-derived membranes is primarily due to interaction
with the Sec61 complex (Kalies et al., 1994), we conclude that
mycolactone does not prevent the RNC from reaching the Sec61
complex (Fig. 2A, scenario ii), but rather alters the nature of their
interaction (Fig. 2A, scenario iii).
Mycolactone partially inhibits the post-translational ER
translocation of short secretory proteins
Having found that mycolactone blocks the co-translational
translocation of secretory polypeptides through the Sec61
complex, we next wished to test its effect on short secretory
protein (SSP) translocation. We investigated four SSPs, all of which
include a C-terminal OPG2 reporter: hepcidin (HepOPG2), apelin
(ApOPG2), statherin (StathOPG2) and cecropin (CecOPG2). Like
tail-anchored proteins, SSPs can enter the ER lumen through a post-
translational and ribosome-independent mechanism (Johnson et al.,
2013b), but unlike tail-anchored proteins, they do so through the
Sec61 translocon (Cross et al., 2009; Johnson et al., 2012; Lang
et al., 2012). Unlike the classical secretory protein substrates, which
were efficiently blocked by mycolactone (Fig. 1A), and tail-
anchored membrane proteins, which were unaffected (Fig. 1B),
SSPs showed an intermediate level of ER translocation when
synthesised in the presence of mycolactone (Fig. 3A). SSP
translocation persisted even at concentrations threefold higher
than those capable of fully blocking longer secretory proteins
(Fig. 3B, lane 8). Furthermore, with CecOPG2, translocation was
still clearly evident when mycolactone was present at a level tenfold
greater than that used to inhibit co-translational translocation
(Fig. 3B, lane 9 versus lane 10), ruling out the likelihood of any
simple differences in dose dependence for different classes of
substrate. In fact, the amount of ER-translocated material changed
little beyond mycolactone concentrations of 0.5 µg/ml for
StathOPG2, 1 µg/ml for ApOPG2 and 1.5 µg/ml for CecOPG2
(Fig. 3B, lanes 3, 4 and 5, respectively), suggesting that these SSPs
possess an inherent partial resistance to mycolactone-dependent
inhibition of Sec61-mediated translocation.
Although SSPs can enter the ER lumen post-translationally, it is
possible that a proportion of newly synthesised precursors
might access the co-translational SRP-dependent pathway when
synthesised in the presence of ERmicrosomes (cf. Lakkaraju et al.,
2012). In order to establish whether mycolactone is selectively
inhibiting such a co-translational pool, SSP translocation was
analysed using an experimental protocol that is strictly post-
translational, given that ER microsomes were added after
translation had been terminated and any residual nascent chains
released from their ribosome. Although PPαF translocation was
fully blocked by mycolactone in the co-translational system
(Fig. 3C, ‘Co-’, lanes 1 and 2), we observed no translocation in the
post-translational system even in the absence of mycolactone
(Fig. 3C, ‘Post-’, lanes 1 and 2), confirming PPαF as an obligate
co-translational substrate in our cell-free system. In contrast, the
translocation of SSPs was apparent in this post-translational
system and this process was inhibited by mycolactone to a similar
extent as observed when protein synthesis was carried out in the
presence of ERmicrosomes (Fig. 3C, lanes 3–8 compare ‘Co-’ and
‘Post-’). The SRP-dependent pathway can also be selectively
disabled by limited trypsinisation, which degrades the α-subunit
of the SRP receptor α (SRα, also known as SRPR) while leaving
the pore-forming α-subunit of the Sec61 complex largely intact
(Abell et al., 2004; Fig. 3D). Hence, following trypsinisation,
obligate co-translational substrates such as PPL cannot be
translocated and processed by the signal peptidase (Fig. 3E,
lanes 1 and 2). Nevertheless, efficient SRP-independent
translocation of both ApOPG2 and CecOPG2 was observed
following this trypsinisation (Fig. 3E, lanes 3 and 5), and the
inhibitory effect of mycolactone was similar to that previously
observed (Fig. 3E, lanes 4 and 6, compare with Fig. 3B). We,
therefore, conclude that mycolactone also inhibits Sec61-
dependent translocation when it occurs in a strictly post-
translational manner, but the extent of this inhibition appears to
be substrate specific.
Inhibition of SSP translocation bymycolactone is dependent
on both signal sequence identity and mature domain length
Having observed that the post-translational translocation of different
SSPs into the ER lumen was blocked by mycolactone to different
extents, we next wished to investigate what determined this
specificity. Since some inhibitors of Sec61 are highly signal
sequence-dependent (Kalies and Römisch, 2015), we first
addressed the potential role of the signal sequence in determining
mycolactone sensitivity. To do this, αFCecOPG and CecαF,
previously characterised chimeric proteins containing the signal
sequences from PPαF (co-translational and highly mycolactone
sensitive) and CecOPG2 (post-translational and highlymycolactone
resistant), respectively, were analysed together with their parental
proteins (Fig. 4A; Johnson et al., 2013a). Although parental
CecOPG2 is particularly refractive to mycolactone inhibition
(Fig. 3A,B), replacing its endogenous signal sequence with that of
PPαF generated a post-translational αFCecOPG chimera that was
noticeably more sensitive to mycolactone (Fig. 4A, lanes 3, 4, 7 and
8). However, although the signal sequence of CecOPG2 is more
hydrophobic than that of PPαF (see Fig. 4A and accompanying
legend), replacing the normal PPαF signal sequence with that of
CecOPG2 had little effect, and translocation of the resulting CecαF
chimera was also efficiently inhibited by mycolactone (Fig. 4A,
lanes 1, 2, 5 and 6). Taken together, these data suggest that signal
sequence identity plays some role in determining the mycolactone
sensitivity of post-translationally translocated SSPs, but does not
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make a major contribution to the mycolactone-induced inhibition of
co-translationally translocated substrates.
In addition to signal sequence identity, the sensitivity of SSP
translocation to mycolactone appeared to show some relationship to
the length of the mature domain of the protein (Fig. 3A). For
example, ApOPG2 (95 residues long including the signal sequence)
was inhibited more effectively by mycolactone than the shorter
CecOPG2 (82 residues including the signal sequence). To test this
potential relationship further, a series of apelin truncations that all
retained the same C-terminal OPG reporter were generated. When
the length of these apelin-derived polypeptides was reduced from 91
to 63 or 55 residues, mycolactone was noticeably less effective at
inhibiting their ER translocation, resulting in a higher proportion of
N-glycosylation following mycolactone treatment (Fig. 4B). We
therefore conclude that the size of the mature domain can contribute
to the mycolactone sensitivity of SSPs.
Trapping a post-translational translocation intermediate at
the Sec61 translocon
Although artificially generated RNCs have been extensively used
to probe the environment of translocating polypeptides through the
co-translational route (Gilmore et al., 1991), this approach is not
well-suited to study post-translational translocation. We therefore
sought to artificially trap a translocating SSP by incorporating the
29-residue ADR1 zinc finger at the C-terminus of a truncated form
of cecropin (herein denoted ‘CecZnF’) such that this region of the
polypeptide can form a stable, folded conformation in the presence
of zinc ions (Conti et al., 2014). Furthermore, the version of CecZnF
that we created included two consensus sites for N-glycosylation
(N40 and N62) to provide a reporter for ER translocation (Fig. 5A).
In the absence of added zinc ions, CecZnF is capable of efficient
post-translational translocation into ER-derived microsomes, as
indicated by N-glycosylation of the polypeptide (Fig. 5B, lane 1).
Increasing the concentration of exogenous zinc ions caused the fully
glycosylated form of CecZnF to disappear (Fig. 5B, lanes 1–3,
see ‘+2g’), and resulted in a concomitant increase in the non-
glycosylated form (Fig. 5B, lanes 1–3, see ‘0g’). Addition of zinc ions
led to no such change for a mutant form of CecZnF that lacks Cys58
andCys61 andwhich therefore cannot co-ordinate zinc ions (hereafter
denoted CecZnF −Cys) (Fig. 5B, lanes 4–6). We also noted that
addition of zinc ions led to an increase in the amount of singly
glycosylated CecZnF (Fig. 5B, lanes 1–3, see ‘+1g’), which we
Fig. 3. Mycolactone partially inhibits post-translational SSP translocation into the ER. (A) Various SSPs containing C-terminal OPG2 tags [hepcidin
(HepOPG2, 102 residues), apelin (ApOPG2, 95 residues), statherin (StathOPG2, 82 residues) and cecropin (CecOPG2, 82 residues)] were in vitro translatedwith
or without mycolactone (left panel), and their ability to translocate was assessed by dividing the amount of doubly glycosylated material (+2g) in the presence of
mycolactone (Myco) by the amount in the absence of mycolactone (right panel). Results are mean±s.d. (for CecOPG2 n=9; for StathOPG2 and CytB5OPG2,
n=6; for all other substrates, n=8). 0g, non-glycosylated; +1g, singly glycosylated. (B) StathOPG2, ApOPG2 andCecOPG2were in vitro translated in the presence
of increasing concentrations of mycolactone. Final concentrations (µg/ml) of mycolactone from left to right are: 0, 0.2, 0.5, 1, 1.5, 2, 2.5 and 3. CecOPG2 was also
tested with 10 µg/ml mycolactone (lane 10) or an equivalent volume of DMSO only (lane 9). Between 0 and 3 µg/ml mycolactone, CecOPG2 was recovered using
native immunoprecipitation as opposed to membrane recovery by high-speed centrifugation in order to demonstrate that the decrease in glycosylated material
was not due to an inhibition of total material. (C) Translocation of SSPs into rough microsomes in the presence of mycolactone was tested in either a co-
translational (Co-, top panel) or a post-translational (Post-, bottom panel) in vitro translocation system. (D)Western blot of salt-washed roughmicrosomes (KRMs)
that had been incubated with or without 1 µg/ml trypsin on ice for 1 h using antisera raised against either SRα or Sec61α (C-term). (E) The indicated substrates
were in vitro translated with or without mycolactone in the presence of trypsinised KRMs. nc, signal sequence not cleaved.
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confirmed was due to modification of residue N40 (Fig. S3A). We
therefore postulated that binding of zinc ions leads to two distinct
populations of CecZnF (Fig. 5C): (1) a singly glycosylated, yet
fully translocated population, where N62 is occluded from the
oligosaccharyltransferase due to folding of the zinc finger (McGinnes
and Morrison, 1997; Schulz et al., 2009); and (2) a non-glycosylated
population that is trapped by the Sec61 translocon.
In order to test this hypothesis, we used chemical crosslinking to
probe the local environment of CecZnF in the presence and absence
of exogenous zinc ions. This approach revealed the appearance of an
adduct between CecZnF and Sec61α, together with a reduction in
crosslinking between CecZnF and the ER lumenal chaperone
calreticulin (CRT, also known as CALR; Fig. 5D; Fig. S3B).
Furthermore, upon EndoH treatment, no size shift was observed for
the Sec61α adduct (Fig. S3C), confirming that its CecZnF
component is not glycosylated, but is instead a bona fide post-
translational trapped intermediate. The faint appearance of the
CecZnF and Sec61α adduct observed in the absence of additional
zinc ions (Fig. 5D, lanes 2 and 6) is most likely due to folding
induced by endogenous zinc ions (Conti et al., 2014). Like other
SSPs (see Figs 3A and 4A), CecZnF displays only a partial
sensitivity to mycolactone, with over 50% of the substrate still being
translocated in the presence of the compound (Fig. 5E).
Furthermore, CecZnF is slightly more sensitive to mycolactone
than its CecZnF −Cys control (Fig. 5E), suggesting that the folding
and/or conformation of the mature domain can influence the
sensitivity of SSPs to mycolactone.
Despite only partially inhibiting CecZnF translocation,
mycolactone strongly diminished the DSS-mediated adduct
formed between CecZnF and Sec61α in the presence of zinc ions
(Fig. 5F, lane 5 versus lane 6). This observation suggests that
mycolactone does not preclude access of the substrate to the
translocon pore, but changes the architecture of the translocon in
such a way that it prevents the formation of this amine-dependent
crosslinking product. Interestingly, mycolactone could disrupt the
ability of trapped CecZnF chains to crosslink Sec61α even when it
was added after the ER-targeting step had occurred and trapped
intermediates had already accumulated (Fig. 5F, lane 7 versus lane
8). In contrast, mycolactone was unable to reverse the juxtaposition
of nascent PPL86 chains that had already docked at the Sec61
complex as part of a pre-existing RNC translocation intermediate
(Fig. 5G, lane 3 versus lane 4). Therefore, our observations with
mycolactone highlight differences between co- and post-
translationally delivered secretory proteins both in their initial
engagement with the Sec61 complex and subsequent translocation
into the ER lumen.
Mycolactone alters the crosslinking profile and protease-
sensitivity of Sec61α
Taken together, the data outlined above support a model where
mycolactone induces a conformational change at the ER translocon
and/or its associated components that results in defective protein
translocation through the Sec61 complex. Having ruled out any
effect on ribosome binding (Fig. S2D), we employed crosslinking to
Fig. 4. Inhibition of SSPs bymycolactone is dependent on signal sequence identity andmature domain length. (A) Chimeras of PPαFandCecOPG2were
generated by swapping of their respective signal sequences (left panel) and their translocation into roughmicrosomes in the presence of mycolactone (Myco) was
assessed as described above (middle and right panels). Results are mean±s.d. (n=3). The net hydrophobicity (Kyte-Doolittle scale, KD) of the full PPαF and
CecOPG2 signal sequences were estimated by averaging the individual values obtained using http://web.expasy.org/protscale/ (window size of 9). Alternatively,
the ΔGapp for the same regions was calculated using http://dgpred.cbr.su.se/ (Hessa et al., 2007). It should be noted that more hydrophobic signal sequences are
denoted by more positive KD values and more negative ΔGapp values. (B) A series of apelin truncations, including C-terminal OPG tags, were generated (left
panel) and their translocation into rough microsomes in the presence of mycolactone was assessed (middle and right panels). Results are mean±s.d. (n=4). The
mycolactone sensitivity of the longest apelin-derived construct (Ap91) was found to be significantly different to both Ap63 and Ap55. ***P≤0.001; ****P≤0.0001;
ns, not significant (one-way ANOVA).
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probe the local environment of four translocon and translocon-
associated components: Sec61α, Sec61β, Sec62 and TRAM (also
known as TRAM1), in the presence and absence of mycolactone
(Fig. S4A–D). Treatment of rough microsomes with mycolactone
resulted in a modest qualitative reduction in the intensity of DSS-
dependent adducts containing Sec61α (Fig. S4A, lanes 5 and 6,
asterisk) and Sec61β (Fig. S4B, lanes 5 and 6, asterisk). It remains to
be confirmed that these two ∼47-kDa products represent a single
adduct containing both Sec61α and Sec61β (Kalies et al., 1998).
Nevertheless, these data are consistent with a subtle conformational
change at the Sec61 translocon following mycolactone treatment, as
further suggested by the enhancement of a faint ∼75 kDa BMH-
dependent adduct of Sec61β that is observed after mycolactone
treatment of rough microsomes (Fig. S4B, lanes 3 and 4, double
asterisk).
As an alternative approach to study mycolactone-induced
conformational changes of key translocon components, limited
proteolysis was performed using high-salt-washed rough
microsomes that had been pre-incubated with either mycolactone
or a vehicle control. Trypsinisation of control membranes and
Fig. 5. Mycolactone affects co- and post-translationally trapped intermediates at the Sec61 translocon differently. (A) Schematic of CecZnF indicating
N-glycosylation sites (Y symbols), as well as cysteine and histidine residues involved in coordinating the zinc ion in the C-terminal ADR1 zinc finger domain.
(B) Post-translational translocation of CecZnF and CecZnF −Cys (a folding deficient mutant) into roughmicrosomes with increasing concentrations of exogenous
zinc ions (Zn2+). 0g, non-glycosylated ; +1g, singly glycosylated; +2g, doubly glycosylated. (C) Cartoon depicting the two postulated populations of CecZnF in the
presence of exogenous Zn2+ (0.5 mM): (1) fully translocated but only singly glycosylated and (2) non-glycosylated and trapped at the Sec61 translocon.
(D) DSS crosslinking analysis of CecZnF in the presence or absence of exogenous Zn2+ (0.5 mM). Samples were analysed by SDS-PAGE either following
isolation of rough microsomes by ultracentrifugation (left panel) or by immunoprecipitation (IP) using antisera raised against Sec61α (C-terminus) (right panel).
(E) Post-translational translocation of CecOPG2, CecZnF and CecZnF–Cys was assessed with only endogenous Zn2+ ions present in the presence or absence
of mycolactone (Myco). Results are mean±s.d. (n=3). (F) DSS crosslinking analysis of CecZnF with or without additional Zn2+ ions and with mycolactone
added either before addition of rough microsomes (Pre-) or after addition of rough microsomes (Post-). (G) As for F, but BMH crosslinking was performed
on PPL86.
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blotting for an N-terminal epitope of Sec61α revealed two
previously characterised digestion products that arise from
cleavage at cytosolic loops L6 and L8 of this polytopic protein
(Fig. 6A; see Song et al., 2000). Pre-treatment of membranes with
mycolactone resulted in a kinetic delay in the appearance of these
proteolytic fragments (Fig. 6B,D,E), indicating that Sec61α had
become more resistant to trypsin cleavage at these sites. In contrast,
Sec61β showed no difference in sensitivity to trypsin following
mycolactone treatment (Fig. 6C,F), thus ruling out the possibility
that mycolactone affects trypsin activity per se. Hence, mycolactone
treatment alters the protease sensitivity of Sec61α, the central pore-
forming component of the ER translocon (Van den Berg et al.,
2004).
DISCUSSION
In this study, we characterise the inhibitory mechanism of the
polyketide-derived virulence factor mycolactone, and confirm that
its principal target is the Sec61 translocon of the ER membrane.
Furthermore, we observe clear differences in the effects of
mycolactone on co- and post-translational translocation through
the Sec61 translocon. Mycolactone efficiently inhibits co-
translational translocation of polypeptides into the ER, whereas
post-translationally translocated SSPs typically show only a partial
inhibition in the presence of mycolactone. The extent to which SSP
translocation is inhibited by mycolactone can apparently be
influenced by signal sequence hydrophobicity, as well as the
length and folding propensity of the mature domain. In both cases,
these effects on protein translocation are likely brought about by a
mycolactone-induced conformational change in the pore-forming
Sec61α subunit, which we speculate might stabilise a closed
conformation of the Sec61 complex (see below). These findings
highlight previously unappreciated differences between Sec61-
mediated co- and post-translational translocation, and provide
further molecular insights into the pathology of Buruli ulcer.
Mycolactone inhibits co-translational translocation through
Sec61
The previously characterised small-molecule inhibitor eeyarestatin I
(ESI) has been proposed to inhibit co-translational Sec61-
dependent translocation into the ER by preventing the transfer of
RNCs from the SRP receptor to Sec61 (Cross et al., 2009), and we
find that adducts between a trapped PPL75 nascent chain and both
Sec61α and Sec61β are clearly diminished in the presence of ESI
(Fig. S2C). However, it is worth noting that whereas ESI treatment
completely inhibited crosslinking of Sec61α to a trapped membrane
protein intermediate (Cross et al., 2009), it only partially inhibits its
crosslinking to PPL75 (Fig. S2C). The difference between these two
precursors suggests that the effects of ESI on ER translocon might
be more complex than previously envisaged (Cross et al., 2009). In
contrast to the effects of ESI, although mycolactone treatment also
results in a substantial loss of crosslinking to Sec61α, crosslinking
between nascent PPL75 and Sec61β is actually enhanced (Fig. 2E).
Fig. 6. Mycolactone induces a conformational change in the Sec61α subunit of the ER translocon. (A) Schematic showing Sec61α and Sec61β topologies
in the ER membrane with trypsin cleavage sites in Sec61α loops L6 and L8 indicated. Western blotting of trypsinised KRMs was performed with an antiserum
raised against either Sec61α (N-terminus) (B) or Sec61β (C) in the presence or absence of mycolactone (Myco). Degradation products corresponding to cleavage
at Sec61α loops L8 (α393) and L6 (α274) are indicated, as well as an unidentified degradation product at∼27 kDa (*). Full-length Sec61β is also indicated (β). FLα,
full-length Sec61α. (D–F) Relative band intensity of α393, α274 and β over the 60-min trypsinisation. Results are mean±s.d. (n=3).
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This finding suggests that rather than preventing the delivery of co-
translational substrates to the ER translocon per se, mycolactone
changes the nature of the Sec61–RNC interaction at a post-targeting
step.
Enhanced crosslinking of nascent polypeptides to Sec61β has been
observed with the cyclodepsipeptides CAM741 and cotransin, which
selectively perturb ER translocation in a signal-sequence-specific
manner (Garrison et al., 2005; Besemer et al., 2005; Harant et al.,
2007). In contrast, the mycolactone-dependent inhibition of co-
translational substrates appears to be unaffected by the signal
sequence identity of the precursors in this study (Figs 1A and 4A),
more closely resembling the inhibitory effects of cotransin CT09
(Maifeld et al., 2011). This suggests that mycolactone can inhibit the
co-translational translocation of a wide range of substrates, consistent
with the near complete loss of glycosylated and secreted proteins
observed when mammalian cells are treated with the compound (Hall
et al., 2014). Furthermore, although the effects of cyclodepsipeptides
on the ER translocation of bona fide SSPs are poorly characterised
(Johnson et al., 2013a), the inhibitory effect of mycolactone that we
observe on this class of substrate is detailed below.
Although we observe that mycolactone alters the interaction
between RNCs and Sec61α, it appears less capable of doing so once
the targeting of PPL86-RNCs to the Sec61 complex has already
taken place (Fig. 5G). Previous studies have suggested that PPL86-
RNCs form a tight interaction with the Sec61 complex that
precludes access of cytosolic factors to the nascent chain (Connolly
et al., 1989; Hegde and Lingappa, 1996). We therefore speculate
that RNC docking at the Sec61 complex might either obstruct the
target site of mycolactone, or that, once formed, the stability of this
ribosome-bound complex is such that it prevents conformational
changes in Sec61α that mycolactone otherwise induces. In support
of this, we find that the local environment of an SSP translocation
intermediate that is trapped at the Sec61 complex in the absence of a
ribosome can be perturbed upon mycolactone treatment (Fig. 5F).
However, we cannot rule out the possibility that our trapped SSP
translocation intermediate is capable of cycling on and off the
translocon, and that mycolactone prevents its proper interaction with
Sec61α by acting when our substrate is not bound to the Sec61
complex. It is worth noting that the mycolactone resistance of the
RNC docked at the Sec61 complex has been observed using an
artificial in vitro translocation intermediate. In a physiological
setting, the rapid recycling of ribosomes on and off the ER
translocon (Jan et al., 2014) would therefore afford no long-term
resistance of co-translational substrates to mycolactone.
Mycolactone has different effects on Sec61-mediated
co- and post-translational translocation
Mycolactone inhibits SSP translocation into the ER to a lesser extent
than for co-translationally translocated substrates (Fig. 3A versus
1A). Moreover, this partial inhibition persists in a strictly post-
translational and ribosome-independent in vitro system (Fig. 3C–E),
demonstrating that the effect of mycolactone on ER translocation
cannot be explained solely by a disruption of the RNC–Sec61
interaction. Rather, mycolactone treatment alters the Sec61
translocon in such a way that limits its role in both co- and post-
translational translocation. Interestingly, the production of several
chemokines that bear the hallmarks of SSPs is affected in cell
culture models (Coutanceau et al., 2007; Hall et al., 2014). We
speculate that the properties of these chemokines are akin to the
more sensitive SSPs, such as apelin, that we have defined using an
in vitro system. Alternatively, in a cellular context, mycolactone
treatment might simply inhibit the renewal of key cellular
components that depend upon the co-translational pathway,
including Sec61α (Knight and High, 1998).
Unlike co-translational substrates, the extent of SSP inhibition by
mycolactone shows some dependence on the identity of the signal
sequence, and we speculate that this might be due to differences in
hydrophobicity (see Johnson et al., 2013a). Hence, when the
endogenous signal sequence of CecOPG2 is replaced with the less
hydrophobic signal from PPαF, the resulting chimera is more
sensitive to mycolactone (Fig. 4A). Additionally, the ER
translocation of SSPs can be made less sensitive to mycolactone
by truncating the mature domain (Fig. 4B) or reducing its propensity
to fold prior to translocation (Fig. 5E). It has been shown that signal
sequence hydrophobicity must be sufficient to induce translocon
gating (Jungnickel and Rapoport, 1995; Trueman et al., 2012), and
that point mutations and small-molecule inhibitors can alter this
‘hydrophobicity threshold’ by stabilising either ‘open’ or ‘closed’
conformations of the Sec61 translocon (Junne et al., 2007;
MacKinnon et al., 2014; Voorhees and Hegde, 2016). A recent
study has identified decatransin as a molecule capable of inhibiting
co- and post-translational translocation into the ER, and found this
compound to be much less effective when the closed conformation
of Sec61 was destabilised by introducing point mutations into the
so-called plug domain (Junne et al., 2015). Similar mutations
conferred partial resistance to the translocation inhibitor CT8, as
did increasing the hydrophobicity of the apolar region responsible
for inducing channel gating (MacKinnon et al., 2014). Our
observations are therefore consistent with a model where
mycolactone stabilises a closed conformation of the Sec61
translocon that, in the case of post-translational translocation,
requires a more hydrophobic signal sequence to induce translocon
opening, and which is less permissive to the post-translational
translocation of mature domains that are long or stably folded. One
intriguing possibility is that these different small-molecule
inhibitors of the ER translocon, including mycolactone, all bind
to a similar region of the Sec61α subunit (MacKinnon et al., 2014,
2007).
The stabilisation of a closed Sec61 conformation by mycolactone
is also consistent with our observation that co-translationally
translocated substrates are prevented from entering the ER, yet,
unlike SSPs, the translocation of these substrates is not enhanced by
increasing signal sequence hydrophobicity (Fig. 4A). At present we
can only speculate as to the molecular basis for this difference. It
could be that a mycolactone-dependent stabilisation of a closed
Sec61 conformation can indeed be overcome by increasingly
hydrophobic signal sequences present on co-translational substrates,
but the translocation of their large mature domains is still precluded,
in contrast to the shorter and less structured SSPs (Figs 3A, 4B and
5E). Alternatively, mycolactone might critically interfere with
ribosome-dependent priming of the Sec61 complex (Pfeffer et al.,
2015; Voorhees and Hegde, 2016). Hence, although mycolactone
has no effect on the binding of ribosomes to ER membranes
(Fig. S2D), we observe discrete changes in the architecture of the
RNC–Sec61 interaction as evidenced by crosslinking of the nascent
chain to Sec61 subunits (Fig. 2E). Additionally, the cytosolic
regions of Sec61α that show altered trypsin sensitivity upon
mycolactone treatment (Fig. 6B,D,E) overlap with domains that are
implicated in ribosome binding (Cheng et al., 2005; Voorhees et al.,
2014). On this basis, we favour a model where mycolactone
perturbs an interaction between the ribosome and the Sec61
complex that is necessary for co-translational translocation to
progress (Becker et al., 2009; Cheng et al., 2005; Gogala et al.,
2014; Pfeffer et al., 2015; Voorhees and Hegde, 2016), and thereby
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efficiently inhibits this pathway irrespective of the precise signal
sequence carried by a precursor protein. In summary, mycolactone
inhibits both co- and post-translational translocation through the
Sec61 translocon, and provides a promising tool for further
delineating the complexities of protein translocation across the ER
membrane.
MATERIALS AND METHODS
Synthetic mycolactone A/B was a gift from Yoshito Kishi, Harvard
University, MA (Song et al., 2002). Unless otherwise stated, all standard
laboratory reagents were obtained from Merck or Sigma.
DNA constructs
HepOPG2 and CecZnF were obtained from Genscript and subcloned into
pcDNA5 (Invitrogen). All other short secretory protein and tail-anchored
protein constructs were as previously described (Johnson et al., 2012; Rabu
et al., 2008). CecOPG2 and PPαF chimeras were prepared as described
previously (Johnson et al., 2013a). PPαF was from Jeffrey Brodsky
(University of Pittsburgh, Pittsburgh, PA). PSAP was obtained from
Origene. PPL was as described previously (High et al., 1993). cDNAs were
generated by PCR and transcribed with T7 polymerase (Promega).
Antibodies
The mouse monoclonal antibody recognising the opsin tag (Adamus et al.,
1991) and the rabbit antiserum against Sec61α (N-terminus) (Laird and
High, 1997) were as described previously. Rabbit antisera against: SRP54,
Sec61β and SRα were gifts from Bernhard Dobberstein (University of
Heidelberg, Heidelberg, Germany); Sec61α (C-terminus) and Sec62 from
Richard Zimmermann (University of Saarland, Homburg, Germany); and
PPL from Sharon Tooze (Francis Crick Institute, London, UK). A rabbit
antiserum recognising an internal peptide of the human 25-kDa subunit of
the signal peptidase complex (SPCS2) was custom made by Eurogentec.
Anti-calreticulin was purchased from Affinity Bioreagents (catalogue
number, PA3-900). Anti-RPL19 was purchased from Santa Cruz
Biotechnology (catalogue number sc-100830). Antibody dilutions are
given in the relevant section.
In vitro translation and translocation assays
Translation reactions (25 µl) were carried out using nuclease-treated rabbit
reticulocyte lysate (Promega). Translations were performed in the presence
of EasyTag EXPRESS35S Protein Labelling Mix containing [35S]
methionine (Perkin Elmer) (0.769 MBq; 43.5 TBq/mmol). Amino acids
minus methionine (Promega) were added to 30 µM. 1 µg of in vitro
transcribed RNA was then added. For co-translational reactions, 10% (v/v)
nuclease-treated roughmicrosomes [optical density at 280 nm (OD280)=44/ml]
were added and the samples were incubated for 30 min at 30°C. For
post-translational reactions, the sample was incubated for 15 min at 30°C in
the absence of rough microsomes. Puromycin was added to 0.5 mM
following the translation and incubated at 30°C for 5 min to ensure
effective release of the polypeptide from the ribosome. 2 µl of rough
microsomes (OD280=44/ml) were added and the sample was incubated for a
further 20 min at 30°C. Mycolactone in DMSO was first diluted to 25 µg/ml
using 0.5% (w/v) BSA in nuclease-free water before addition to the
translation mixture to give a final concentration of 1 µg/ml. Control was an
equivalent volume of 10% (v/v) DMSO in 0.5% (w/v) BSA. For the
co-translational system, mycolactone was present during translation. For
the post-translational system, mycolactone was added after puromycin
treatment, but before rough microsome addition. To look at folding of the
CecZnF zinc finger, ZnCl2 solution in 6 mM HCl was added to a final
concentration of 0.1 or 0.5 mM after puromycin treatment but before rough
microsome addition, and incubated at 30°C for 3 min.
Membrane recovery and visualisation
Membranes were recovered by centrifugation through an 80-µl high-salt
cushion [0.75 M sucrose, 0.5 M KOAc, 5 mM Mg(OAc)2, 50 mM Hepes-
KOH, pH 7.9] at 100,000 g for 10 min at 4°C in a TLA100 rotor
(Beckmann). The membrane pellet was resuspended in 20 µl low-salt buffer
[100 mM sucrose, 100 mM KOAc, 5 mM Mg(OAc)2, 50 mM Hepes-KOH
pH 7.9, 1 mM DTT] and treated with 250 µg/ml RNase A at 37°C for
10 min. Where indicated, samples were also treated with endoglycosidase H
(EndoH) (New England Biolabs) as described by the supplier. The resulting
samples were analysed by SDS-PAGE and phosphorimaging using a
Typhoon FLA-7000 (GE Healthcare). Images were then processed using
Adobe Photoshop and Adobe Illustrator. Data were quantified using Aida
(Raytek) and statistical analysis (one-way ANOVA) was performed using
GraphPad (Prism). The exact sample size (n) for each experimental group is
provided in the appropriate figure legends. In each case, nwas defined by the
number of times the substrate was tested in the same experimental system
and so represents technical replicates.
Crosslinking and immunoprecipitation
For crosslinking PPL86 to cytosolic components, PPL86-RNCs were
generated by carrying out in vitro translation for 15 min in the absence of
rough microsomes, as described above. The RNC pellet was isolated by
centrifuging 160,000 g for 20 min at 4°C, before being resuspended in low-
salt buffer. DSS (in DMSO stock) was added to a final concentration of
1 mM (control was an equivalent volume of DMSO) and was incubated at
30°C for 10 min before being quenched with 50 mM glycine. Denaturing
immunoprecipitation was then carried out by adding SDS to 1% (v/v) and
heating at 70°C for 10 min. Nine volumes of Triton immunoprecipitation
buffer (10 mM Tris-HCl pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton
X-100, 5 mM PMSF, 1 mM methionine) were added, and the appropriate
antiserum was added at 1:200. Samples were incubated for 15 h at 4°C with
constant agitation. Protein-A–Sepharose beads (Genscript) were added to
10% (v/v) and samples were incubated at 4°C for a further 2 h. Protein-A–
Sepharose beads were then recovered by centrifuging at 13,000 g for 1 min
and washed with Triton immunoprecipitation buffer before being heated at
70°C for 10 min in SDS sample buffer. For crosslinking to translocon
components, after membranes were recovered and resuspended in low-salt
buffer as described above, the appropriate chemical cross-linker was added
to 1 mM and incubated at 30°C for 10 min. The reaction was quenched by
adding 20 mM β-mercaptoethanol for BMH-treated samples, or 50 mM
glycine for DSS-treated samples. For PPL truncations, samples were also
carbonate-extracted by adding 150 µl of 0.1 M Na2CO3 (pH 11.3),
incubating for 15 min on ice, and recovering the membrane fraction by
centrifuging at 100,000 g for 10 min at 4°C. Samples were then either
analysed directly by SDS-PAGE, or were first immunoprecipitated under
denaturing conditions as described above. Native immunoprecipitation of
CecOPG2 during mycolactone titration (see Fig. 3B) was performed as
above, with the exception that Triton immunoprecipitation buffer was added
to the total translation reaction without rough microsome recovery through a
high-salt cushion, and no SDS was added.
Microsome trypsinisation and western blotting
Salt-washed rough microsomes (denoted KRMs) were prepared as
described previously (Walter and Blobel, 1983) and mycolactone was
added to 2.5 µg/ml. Control was an equivalent volume of 10% (v/v) DMSO
in 0.5% (w/v) BSA. KRMs were then treated with 1 µg/ml trypsin on ice for
1 h, with further protease activity being inhibited by the addition of 5 mM
PMSF and incubating on ice for 10 min. To degrade Sec61α, KRMs were
subjected to a second round of high-salt washing before incubating with
1 µg/ml trypsin on ice. 5 mM PMSF was added at the indicated time points
and the samples were incubated on ice for a further 10 min. Samples were
then separated by SDS-PAGE and were analysed by using western blotting
as described previously (Johnson et al., 2012). For blotting, anti-Sec61α (N-
terminus) antibodies were used at a dilution of 1:1000 and anti-Sec61β at
1:3000. Blots were quantified using Image Studio (LI-COR Biosciences).
Microsome crosslinking and western blotting
To perform crosslinking of translocon subunits and associated components,
as seen in Fig. S4, rough microsomes were incubated with either 2.5 µg/ml
mycolactone or an equivalent volume of DMSO in 0.5% (w/v) BSA for
5 min at 30°C. Either BMHor DSSwas added at 100 µM final concentration
and incubated at 30°C for 10 min. The reactions were quenched by adding
20 mM β-mercaptoethanol for BMH-treated samples, or 50 mM glycine for
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DSS-treated samples. Samples were then carbonate-extracted as described
above and were analysed by performing SDS-PAGE and western blotting as
described previously (Johnson et al., 2012). For blotting, all primary
antibodies were used at a dilution of 1:1000 apart from anti-Sec61β, which
was used at 1:3000.
Ribosome-binding assay
Ribosomes were isolated from rabbit reticulocyte lysate (Promega). 400 µl
of lysate was centrifuged at 13,000 g for 20 min at 4°C to remove debris.
The supernatant was then applied onto a cushion of 0.5 M sucrose in binding
buffer [20 mMHEPES (pH 7.6), 10 mMNaCl, 5 mMMg(OAc)2, 150 mM
KOAc, 1 mM DTT] and centrifuged at 200,000 g for 30 min at 4°C. The
pellet was resuspended in 400 µl of 10% (v/v) glycerol in binding buffer.
Ribosomes were again centrifuged at 13,000 g and 19 µl of the supernatant
was added to 2 µl EDTA-treated and high-salt-washed rough microsomes
[denoted EKRMs, prepared as described previously (Jadhav et al., 2015)].
The concentration of the EKRMs was equivalent to rough microsomes of
OD280=44/ml, as determined by blotting for SPC25. Samples were
incubated for 10 min at 30°C with 1 µg/ml mycolactone or an equivalent
volume of 10% (v/v) DMSO in 0.5% (w/v) BSA. Control samples were
incubated with either 5 mM EDTA or rough microsome buffer in place of
EKRMs. Membranes were then recovered by centrifuging at 13,000 g for
10 min at 4°C before being analysed by using SDS-PAGE and western
blotting as described previously (Johnson et al., 2012). For blotting, anti-
SPC25 was used at 1:2000 and anti-RPL19 at 1:500. The relative amount of
bound ribosomes was calculated by dividing the amount of ribosomes
present (determined by blotting for RPL19) by the amount of EKRMs
(determined by blotting for SPC25).
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